- ICH GCP
- Rejestr badań klinicznych UE
Najnowsze wersje próbne
EudraCT Number: 2004-001690-26 | Sponsor Protocol Number: v30 | Start Date: 2005-02-11 | ||||||
Sponsor Name: Craigavon Area Hospital Group Trust | ||||||||
Full Title: The Low HDL On six Weeks statin therapy (LOW) study | ||||||||
Medical condition: Dyslipidaemia (low HDL-cholesterol) | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003941-42 | Sponsor Protocol Number: B4Z-SO-LY15 | Start Date: 2005-02-11 | ||||||
Sponsor Name: Eli Lilly Sweden AB | ||||||||
Full Title: A Randomised, Double Blind Placebo Controlled Study of the Broader Efficacy of Atomoxetine Hydrochloride in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Swedish Children and ... | ||||||||
Medical condition: Attention-Deficit/Hyperactivity Disorder (ADHD) is a common psychiatric disorder that has its onset in childhood, and that is estimated to occur in 3% to 6% of school-age children. ADHD is characte... | ||||||||
|
||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||
Trial protocol: SE (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-004952-38 | Sponsor Protocol Number: MREC/04/4/016 | Start Date: 2005-02-11 | ||||||
Sponsor Name: Prof John Yarnold, Institute of Cancer Research | ||||||||
Full Title: Randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema after radiotherapy for early breast cancer (HOT) | ||||||||
Medical condition: Chronic radiation-induced arm lymphoedema. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-000367-98 | Sponsor Protocol Number: TRA100773 | Start Date: 2005-02-11 | ||||||
Sponsor Name: GlaxoSmithKline Research and Development Limited | ||||||||
Full Title: A double-blind, randomised, placebo-controlled, parallel group study to investigate the efficacy, safety, tolerability, pharmacokinetics and pharmacodynamics of SB-497115-GR, a thrombopoietin recep... | ||||||||
Medical condition: Immune thrombocytopenic purpura (ITP) | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) SE (Completed) DE (Completed) EE (Completed) LV (Completed) IE (Completed) DK (Completed) ES (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-002993-49 | Sponsor Protocol Number: CDP870-027 | Start Date: 2005-02-11 | |||||||||||
Sponsor Name: Celltech R&D Ltd | |||||||||||||
Full Title: A Phase III multicentre, double blind, placebo-controlled, parallel group 52-week study to assess the efficacy and safety of 2 dose regimens of lyophilised CDP870 given subcutaneously as additional... | |||||||||||||
Medical condition: Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) FI (Completed) LT (Completed) SE (Completed) SK (Completed) CZ (Completed) EE (Completed) LV (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004546-41 | Sponsor Protocol Number: 220458-2004; ML18282 | Start Date: 2005-02-10 | ||||||
Sponsor Name: Helsinki University Central Hospital | ||||||||
Full Title: A phase II trial assessing bevacizumab in the treatment of advanced or metastatic angiosarcoma | ||||||||
Medical condition: patients with advanced or metastatic angiosarcoma | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: FI (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002408-13 | Sponsor Protocol Number: C LF 178P 0401 | Start Date: 2005-02-10 | ||||||
Sponsor Name: FOURNIER Laboratories Ireland Ltd | ||||||||
Full Title: A randomised, double-blind study comparing the efficacy and safety of 145mg NanoCrystal® fenofibrate, 10mg ezetimibe and their combination in patients with type IIb dyslipidemia and features of the... | ||||||||
Medical condition: Patients with type IIb dyslipidemia and features of the metabolic syndrome. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) BE (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-005108-33 | Sponsor Protocol Number: Short2-INF-RIBA | Start Date: 2005-02-10 | |||||||||||
Sponsor Name: AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO | |||||||||||||
Full Title: RANDOMISED CONTROLLED STUDY ON EARLY RENSPONSE TO COMBINED ANTIVIRAL THERAPY IN CHRONIC H EPATITIS C PATIENTS GENOTIPE 2 AND 3 WITH HCV-RNA NEGATIVE WEEK 4 | |||||||||||||
Medical condition: SOSTAINED BIOCHEMICAL AND VIROLOGICAL RESPONSE TO COMBINADET THERAPY PEGILATED RIBAVIRIN IN CHRONIC HEPATITIES PATIENTS G 2 AND 3 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-005112-83 | Sponsor Protocol Number: Short1/4-INF-RIBA | Start Date: 2005-02-10 | |||||||||||
Sponsor Name: AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO | |||||||||||||
Full Title: RANDOMISED CONTROLLED STUDY ON EARLY RESPONSE TO COMBINED ANTIVIRAL THERAPY IN CHRONIC EPATITES C PATIENT GENOTIPE 1 AND 4 WITH HCV RNA NEGATIVE WEEK 6 | |||||||||||||
Medical condition: SOSTAINED BIOCHEMICAL AND VIROLOGICAL RESPONSE TO COMBINATED THERAPY PEGILATED RIBAVIRIN IN CHRONIC EPATITIES PATIENTS G 1 AND 4 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004278-10 | Sponsor Protocol Number: 2004/R/AN/04 | Start Date: 2005-02-10 | ||||||
Sponsor Name: Lothian Health Board- University Hospitals Division [...] 1. Lothian Health Board- University Hospitals Division 2. Lothian Health Board University Hospitals Division | ||||||||
Full Title: Determination of the subarachnoid ED50 and ED95 of hyperbaric 0.5% bupivacaine when co-administered with diamorphine hydrochloride for caesarean section | ||||||||
Medical condition: patients undergoing elective caesarean section | ||||||||
|
||||||||
Population Age: Adults | Gender: Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |